Discover
SER
Serina Therapeutics, Inc.
1.92
200 x undefined
100 x undefined
bid
ask
-
0.02
1.03%
150 @ 04:00 PM
1.92 +0.00 (0.00%)
| Ytd | 0.52% | |
| 1y | -68.11% |
1.92
day range
2.00
1.22
52 week range
7.92
| Open | 2.00 | Prev Close | 1.94 | Low | 1.92 | High | 2.00 | Mkt Cap | 28.80M |
| Vol | 72.49K | Avg Vol | 115.86K | EPS | -2.00 | P/E | N/A | Forward P/E | N/A |
| Beta | N/A | Short Ratio | 1.96 | Inst. Own | 3.37% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-08 | 50-d Avg | 1.84 | 200-d Avg | 2.86 | 1yr Est | 0.00 |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|
Profile
Serina Therapeutics, Inc., a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252, a POZ conjugate for the treatment of Parkinson's disease. The company also develops SER 227 for long-acting pain relief; SER 214 to treat Parkinson's disease; and SER 228 for the treatment of epilepsy. In addition, it develops POZ technology in lipid nanoparticle delivered ribonucleic acid vaccines for infectious diseases. Serina Therapeutics, Inc. was founded in 2006 and is based in Huntsville, Alabama.
Insider Holder
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2024-12-16 | BAILEY GREGORY HUGH | Director | 67.24K | Purchase |
| 2023-03-13 | JUVENESCENCE LTD. | Beneficial Owner of more than 10% of a Class of Security | 16.45M | Stock Gift |
| 2024-09-11 | MINTZ STEVEN MICHAEL | Director | 0.00 | Purchase |
| 2023-03-09 | WEST MICHAEL D | Chief Executive Officer | 41.98K | Conversion of Exercise of derivative security |
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Broadwood Capital, Inc. | 85.22K | 460.18K | 0.96% |
| 2024-09-29 | Waverly Advisors, LLC | 67.49K | 364.46K | 0.76% |
| 2024-09-29 | Vanguard Group Inc | 44.50K | 240.30K | 0.50% |
| 2024-09-29 | Geode Capital Management, LLC | 24.03K | 129.74K | 0.27% |
| 2024-09-29 | HighTower Advisors, LLC | 22.43K | 121.14K | 0.25% |
| 2024-09-29 | Millennium Management Llc | 19.26K | 103.98K | 0.22% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Vanguard Total Stock Market Index Fund | 31.80K | 171.71K | 0.36% |
| 2024-10-30 | Fidelity Extended Market Index Fund | 15.59K | 84.20K | 0.18% |
| 2024-09-29 | Vanguard Extended Market Index Fund | 12.33K | 66.60K | 0.14% |
| 2024-09-29 | Northern Small Cap Core Fund | 7.90K | 42.66K | 0.09% |
| 2024-10-30 | Fidelity Series Total Market Index Fund | 3.72K | 20.09K | 0.04% |
| 2024-10-30 | Fidelity Total Market Index Fund | 2.59K | 14.00K | 0.03% |